CytImmune
is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer... Read moreCytImmune
is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer... Read more
News
Aug 23, 2022
PR Newswire
Press Release: CytImmune : Novel Nanotechnology Supercharges Immune System Molecules to Fight Cancer
Apr 13, 2020
SEC
CytImmune: Cytimmune Sciences received $50K in Equity Funding
Jun 18, 2019
CytImmune Blog
CytImmune Blog ASCO 2019
Oct 04, 2018
BioPortfolio
CytImmune: CytImmune Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 06, 2018
CytImmune Blog
CytImmune Blog TNF and T-Cells: A Surprising Result
Jul 27, 2018
BioPortfolio
CytImmune: CytImmune Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 29, 2018
BioPortfolio
CytImmune: CytImmune Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Dec 23, 2017
BioPortfolio
CytImmune: CytImmune Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15112017 Prices from USD $250
Dec 19, 2017
CytImmune Blog
CytImmune Blog Expanded Access Programs List
Nov 19, 2017
CytImmune Blog
CytImmune Blog Future New Drugs for Cancer Patients under Attack from Congressional Tax Bill
CytImmune Competitors
1
2
3
4
5
6
7
8
9
10